Quarterly Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
254,133,000,000 JPY
218,896,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.